In vivo and in vitro studies have shown, that the toll-like receptor-4 (TLR4) pathway with downstream activation of the myeloid differentiation primary response 88 (MyD88) adaptor protein triggers neuroinflammatory processes in the brain of MPS patients. This evidence concerns the gene MYD88 and mucopolysaccharidosis.